产品封面图

慢病毒表达载体pLV-U6-gRNA scaffold-EF

1-NEO
收藏
  • ¥100 - 500
  • ALSTEM
  • CG103
  • 国外
  • 2025年07月12日
    avatar
  • 企业认证

    点击 QQ 联系

    • 详细信息
    • 文献和实验
    • 技术资料
    • 库存

      大量

    • 英文名

      pLV-U6-gRNA scaffold-EF1-NEO

    • 保质期

      详询

    • 供应商

      北京百奥创新科技有限公司

    • 保存条件

      低温

    • 规格

      10 μg at 0.5 μg/μL in TE

    Description:CRISPR (clustered regularly interspaced short palindromic repeats) and CRISPR-associated protein 9 (Cas9) are components of the leading genome or gene editing system, CRISPR-Cas9. Since it was developed in 2012, this gene editing tool has revolutionized biology research, making it easier to study disease and enabling faster drug discovery. The detection of catalytically inactive Cas9 (dCas9) protein has greatly expanded this gene editing system to foster the study of gene expression and regulation in a wide range of organisms. This dCas9 protein lacks the ability to create DNA breaks in the target and serves as a DNA binding protein. When it fuses with a transcriptional repressor such as the Krüppel-associated box (KRAB) repressor or a transcriptional activator such as the tripartite fusion of three transcription activation domains: VP64, p65 and Rta (VPR), it can effectively regress or activate gene expression. To do this, a single guide RNA (sgRNA) of the gene of interest must be present. The Cas9-sgRNA complex binds to DNA sequences that are complementary to the sgRNA and causes a steric block that halts transcript elongation by RNA polymerase in CRISPRi systems. While in CRISPRa systems, the Cas9-sgRNA complex recruits transcription factors to increase desired gene expression.

    Gene specific gRNA that usually targets the promoter region is cloned into one of the sgRNA expression vectors in all the sgRNA vectors, human U6 promoter drives the sgRNA expression. pLV-U6-gRNA scaffold-EF1-NEO sgRNA Lentiviral Vector expresses gRNA with the human U6 promoter and NEO with the EF1 promoter to allow for NEO selection of transduced cells.

    Vector InformationThis is a lentiviral expression vector that contains all the elements for efficient and high yield viral production. A ubiquitous EF1 promoter drives the expression of NEO to allow for the selection of transduced cells. This vector is used in combination with the Cas9-KRAB or the Cas9-VPR to repress or activate the target gene expression, respectively.

    IMPORTANT NOTICEStore the vial at -20°C immediately upon receipt.

     

    产品细节图片1
    Note: Bacterial culture of pLV vectors should be done in medium containing 10 μg/mL Ampicillin. For maximal plasmid yield and quality, we recommend Stbl3 competent cells (Invitrogen).
    Specifications:
    Product Name pLV-U6-gRNA scaffold-EF1-NEO
    Shipping Condition

    Room Temperature - 2 Day Shipping

    Storage and Stability

    Store at -20°C immediately upon receipt. This product is stable for 6 months when stored as directed.

    Quality Control

    This plasmid is sequence verified.

    Restricted Use

    For Research Use Only. Not for use in diagnostic or therapeutic procedures.

    产品细节图片2

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    图标文献和实验
    相关实验
    • Characterization of a PGA-Based Scaffold for Use in a Tissue-Engineered Neo-Urinary Conduit

      testing) and biological characterization (cell viability and proliferation) of a polyglycolic acid-based scaffold used to tissue engineer a Neo-Urinary Conduit™. Such methods are more broadly applicable to characterization of other neo-organ product

    • 慢病毒包装系统简介及应用

      广阔的应用前景。 目前慢病毒也被广泛地应用于表达 RNAi 的研究中。由于有些类型细胞脂质体转染效果差,转移到细胞内的 siRNA 半衰期短,体外合成 siRNA 对基因表达的抑制作用通常是短暂的,因而使其应用受到较大的限制。采用事先在体外构建能够表达 siRNA 的载体,然后转移到细胞内转录 siRNA 的策略,不但使脂质体有效转染的细胞种类增加,而且对基因表达抑制效果也不逊色于体外合成 siRNA ,在长期稳定表达载体的细胞中,甚至可以发挥长期阻断基因表达的作用。在所构建的 siRNA 表达载体

    • Cas9 蛋白过表达慢病毒包装

      一、试剂准备 1、Cas9 过表达慢病毒载体选择。 货号 名称 CR2001 pLV-Cas9-Puro CR2002 pLV-Cas9-Neo CR2003 pLV-Cas9Nick-Puro CR2004

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    询价
    瑞博奥(广州)生物科技股份有限公司
    2025年07月15日询价
    询价
    上海佑隆生物科技有限公司
    2026年01月02日询价
    询价
    北京盛科博源生物科技有限公司
    2025年12月20日询价
    询价
    上海信帆生物科技有限公司
    2025年10月12日询价
    ¥850
    广州辉骏生物科技股份有限公司
    2026年01月01日询价
    慢病毒表达载体pLV-U6-gRNA scaffold-EF1-NEO
    ¥100 - 500